Nebulized Epinephrine Treatment in Pediatric Emergency Department
Halise Akca*, Nilden Tuygun and Can Demir Karacan
Department of Pediatric Emergency Medicine, Dr. Sami Ulus Maternity Children’s Health and Diseases Training and Research Hospital, Turkey
- *Corresponding Author:
- Halise Akca
Department of Pediatric Emergency Medicine
Dr. Sami Ulus Children’s Health and
Diseases Training and Research Hospital
Babur St., No: 44, Altindag, Ankara, Turkey
Tel: +90 312 3056048
E-mail: [email protected]
Received Date: April 26, 2014; Accepted Date: July 28, 2014; Published Date: July 30, 2014
Citation: Akca H, Tuygun N, Karacan CD (2014) Nebulized Epinephrine Treatment in Pediatric Emergency Department. Pediat Therapeut 4:210. doi:10.4172/2161-0665.1000210
Copyright: © 2014 Akca H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Epinephrine, first isolated around 1900, is the main sympathomimetic agent released by the adrenal gland. It plays an integral role in the treatment of several diseases in the emergency department. It effects on alpha and beta adrenergic receptors. In lower doses, it usually causes systemic and pulmonary vasodilatation, with some increase in heart rate and stroke volume. A high dose causes intense systemic vasoconstriction. Its metabolism is rapid and half-life is less than 5 minutes.